PHARPRO Compliance Insights https://www.pharpro.co/ Pharmaceutical compliance, CSV, QA, and GMP training insights from PHARPRO — Jordan's specialist pharma consulting firm. en Sat, 18 Jul 2026 09:00:00 +0300 info@pharpro.co (PHARPRO Consulting Team) info@pharpro.co (PHARPRO) https://www.pharpro.co/images/apple-touch-icon.png PHARPRO Compliance Insights https://www.pharpro.co/ 180 180 Copyright 2026 PHARPRO Consultation Company Pharmaceutical Compliance CSV Validation Training — 5 & 6 August 2026: GAMP 5, IQ/OQ/PQ, Data Integrity & Annex 11 | PHARPRO https://www.pharpro.co/insights/csv-training-august-2026/ https://www.pharpro.co/insights/csv-training-august-2026/ Sat, 18 Jul 2026 09:00:00 +0300 Mohammad Awawdeh CSV Training PHARPRO CSV Training — 5 & 6 August 2026. Two-day intensive covering GAMP 5 Second Edition risk model, IQ/OQ/PQ protocol and report writing, data integrity (ALCOA+), FDA 21 CFR Part 11, EU GMP Annex 11, risk assessment, and a full pharma case study. Online and in-person. Certificate of Completion. Limited to 20 seats — register now. PHARPRO CSV Training — 5 & 6 August 2026

Two-day intensive Computerised System Validation training covering 9 modules: GAMP 5 Second Edition risk model, system inventory & categorisation, risk assessment, URS writing, IQ/OQ/PQ protocol and report writing, data integrity controls (ALCOA+), FDA 21 CFR Part 11, EU GMP Annex 11, Excel validation, and change control. Participants work through real pharmaceutical case studies and leave with draft templates.

Format: Online (live instructor-led) and in-person in Amman, Jordan. Delivered in English with Arabic support. Certificate of Completion for all participants.

Seats are limited to 20 participants. Register at: https://www.pharpro.co/insights/csv-training-august-2026/ or WhatsApp: +962 79 856 5807

]]> Book a PHARPRO DVS Demo — See Pharmaceutical Validation Software in 30 Minutes https://www.pharpro.co/insights/pharpro-dvs-demo-booking/ https://www.pharpro.co/insights/pharpro-dvs-demo-booking/ Sat, 18 Jul 2026 09:00:00 +0300 Mohammad Awawdeh DVS Software Book a free 30-minute PHARPRO DVS demo. See AI-assisted pharmaceutical validation software build IQ/OQ/PQ protocols, URS documents, automated RTM, and audit trails in real time for your specific system type. FDA 21 CFR Part 11 and EU GMP Annex 11 compliant. Pick your slot and book now via Calendly. PHARPRO DVS is AI-assisted validation lifecycle management software providing 30+ document builders covering URS through VSR, automated Requirements Traceability Matrix (RTM), FDA 21 CFR Part 11 e-signatures, audit trail, and EU GMP Annex 11 compliance — all in a single web-based system deployable the same day.

The free 30-minute demo covers: a live walkthrough for your specific use case (LIMS, ERP, SCADA, etc.), AI-assisted document generation for IQ/OQ/PQ and URS, the automated RTM, e-signature and audit trail features, and a Q&A session.

Book your free 30-minute demo →

]]> Software & CSV Gap Assessment for Pharma — Find Every Compliance Gap Before Auditors Do | PHARPRO https://www.pharpro.co/insights/software-csv-gap-assessment/ https://www.pharpro.co/insights/software-csv-gap-assessment/ Sat, 18 Jul 2026 09:00:00 +0300 Mohammad Awawdeh CSV Validation PHARPRO's Software & CSV Gap Assessment identifies compliance gaps in your GxP-critical computerised systems against FDA 21 CFR Part 11, EU GMP Annex 11, and GAMP 5. Deliverable: written gap report with risk-prioritised remediation roadmap. Free initial consultation — no commitment required. A CSV gap assessment identifies which systems are under-validated, which documentation is missing, and prioritises remediation by risk level. PHARPRO's assessment covers all GxP-critical systems: LIMS, ERP (SAP, Oracle), SCADA/DCS, MES, QMS, laboratory instruments, EDMS, and custom software.

Deliverable: Written Gap Assessment Report covering system inventory, regulatory compliance status per system (21 CFR Part 11 / Annex 11 / GAMP 5), gaps with severity classification (critical / major / minor), and a prioritised remediation roadmap with timelines. Post-assessment review meeting included.

Free initial consultation — working session, not a sales call. Request your assessment →

]]> GMP Training — 1 & 2 July 2026: 12 Modules, 16 Hours, Certificate of Completion | PHARPRO https://www.pharpro.co/insights/gmp-training-july-2026/ https://www.pharpro.co/insights/gmp-training-july-2026/ Mon, 23 Jun 2026 09:00:00 +0300 Mohammad Awawdeh GMP Training PHARPRO GMP Training on 1 & 2 July 2026 — two days, 16 hours, 12 key modules covering regulatory frameworks, pharmaceutical quality systems, GMP documentation, data integrity, deviation management, CAPA, validation lifecycle, and GMP inspection readiness. Online and in-person. Certificate of Completion issued to all participants. Limited seats — register now. PHARPRO GMP Training — 1 & 2 July 2026

Comprehensive two-day Good Manufacturing Practice training covering 12 key modules across 16 training hours. Available online (live instructor-led) and in-person. Delivered in English and Arabic. Certificate of Completion for all participants.

Modules covered: Regulatory Framework (WHO/EU/USFDA/SFDA) · Pharmaceutical Quality System · GMP Documentation & Data Integrity · Personnel · Premises · Equipment Qualification · OSD Process Flow · QC Laboratory · Validation Lifecycle · Deviation Management · CAPA & Change Control · GMP Inspection Readiness.

Seats are limited. Register at: https://www.pharpro.co/contact/ or WhatsApp: +962 79 856 5807

Read the full training details →

]]> PHARPRO June 2026 Update: DVS-PQR Module Launched, GAMP 5 Validation Completed & Thermal Mapping Expands to Pakistan https://www.pharpro.co/insights/pharpro-latest-news-june-2026/ https://www.pharpro.co/insights/pharpro-latest-news-june-2026/ Wed, 11 Jun 2026 09:00:00 +0300 Mohammad Awawdeh Company News PHARPRO June 2026 highlights: AI-powered DVS-PQR Module reduces Product Quality Review time by 91%, utility and software validation completed per GAMP 5 Second Edition and EU GMP Annex 11, thermal mapping qualification training launched in Pakistan, and 12+ pharmaceutical clients served this month. PHARPRO June 2026 — Four major milestones: (1) Full utility and software validation project completed per ISPE GAMP 5 Second Edition, C&Q, and EU GMP Annex 11. (2) Thermal Mapping Qualification training initiated for a pharmaceutical client in Pakistan, including equipment and instrumentation consultation. (3) PHARPRO DVS-PQR Module launched — AI-powered Product Quality Review lifecycle software reducing PQR time by 91%. (4) Over 12 pharmaceutical clients served across CSV, QA, CQV, training, and DVS onboarding.

Read the full update →

Arabic version: اقرأ بالعربية →

]]> FDA 21 CFR Part 11 Audit Trail Requirements: What Your System Must Capture https://www.pharpro.co/insights/21-cfr-part-11-audit-trail-requirements/ https://www.pharpro.co/insights/21-cfr-part-11-audit-trail-requirements/ Tue, 26 May 2026 09:00:00 +0300 PHARPRO Consulting Team Data Integrity 21 CFR Part 11 audit trail requirements: what events must be captured, how to configure compliant audit trails, and the most common inspection findings. FDA 21 CFR Part 11 requires that audit trails capture specific events — system access, data creation, modification, and deletion — with timestamps and user attribution. This guide covers exactly what your system must capture and how to evidence compliance during inspections.

Read the full article →

]]> Cleaning Validation Acceptance Criteria: MACO and Carryover Limits Explained https://www.pharpro.co/insights/cleaning-validation-maco-acceptance-criteria/ https://www.pharpro.co/insights/cleaning-validation-maco-acceptance-criteria/ Tue, 26 May 2026 09:00:00 +0300 PHARPRO Consulting Team Cleaning Validation How to set cleaning validation acceptance criteria — calculate MACO, apply 10 ppm and 0.1% dose limits, and choose between rinse and swab sampling methods. Setting the right cleaning validation acceptance criteria is one of the most critical steps in any cleaning validation programme. This guide walks through MACO calculations, the 10 ppm and 0.1% dose limit approaches, and how to document your rationale for EU GMP Annex 15 compliance.

Read the full article →

]]> Data Integrity in Pharmaceutical Manufacturing: ALCOA+ and Regulatory Requirements https://www.pharpro.co/insights/data-integrity-pharmaceutical-manufacturing/ https://www.pharpro.co/insights/data-integrity-pharmaceutical-manufacturing/ Tue, 26 May 2026 09:00:00 +0300 PHARPRO Consulting Team Data Integrity Pharmaceutical data integrity guide — ALCOA+ principles, FDA and EU GMP expectations, common violations, and how to build a robust data integrity programme. Data integrity remains the most cited area in FDA warning letters and EU GMP inspection observations. This guide explains the ALCOA+ principles, what FDA and EU GMP inspectors check, and how to build a programme that withstands scrutiny.

Read the full article →

]]> GAMP 5 Risk Categories Explained: How to Classify Your System https://www.pharpro.co/insights/gamp5-risk-categories-explained/ https://www.pharpro.co/insights/gamp5-risk-categories-explained/ Tue, 26 May 2026 09:00:00 +0300 PHARPRO Consulting Team CSV & Validation GAMP 5 software categories explained — what changed in the Second Edition, how to classify your system, and how category drives validation scope. GAMP 5 classifies computerised systems into categories that determine the depth of validation effort required. The Second Edition simplified the framework. This guide explains how to classify your system correctly and what that means for your documentation scope.

Read the full article →

]]> What Is a GMP Gap Assessment? A Complete Guide https://www.pharpro.co/insights/gmp-gap-assessment-guide/ https://www.pharpro.co/insights/gmp-gap-assessment-guide/ Tue, 26 May 2026 09:00:00 +0300 PHARPRO Consulting Team Quality Assurance What a GMP gap assessment covers, when to conduct one, what regulators expect, and how PHARPRO structures assessments to deliver actionable CAPA plans. A GMP gap assessment identifies compliance shortfalls before a regulatory inspector does. This guide covers when to conduct one, what a structured assessment covers, and how findings should be classified and addressed in a CAPA plan.

Read the full article →

]]> How to Write a User Requirements Specification (URS) for a Computerised System https://www.pharpro.co/insights/how-to-write-urs-computerised-system/ https://www.pharpro.co/insights/how-to-write-urs-computerised-system/ Tue, 26 May 2026 09:00:00 +0300 PHARPRO Consulting Team CSV & Validation How to write a GxP-compliant URS for pharmaceutical computerised systems — structure, content, GxP requirements, and common mistakes to avoid. The User Requirements Specification (URS) is the foundation of every CSV project. A poorly structured URS creates traceability gaps and inspection risk. This guide covers what it must contain, how to structure requirements correctly, and the mistakes that most commonly generate observations.

Read the full article →

]]> IQ OQ PQ Explained: What Each Qualification Phase Requires https://www.pharpro.co/insights/iq-oq-pq-guide/ https://www.pharpro.co/insights/iq-oq-pq-guide/ Tue, 26 May 2026 09:00:00 +0300 PHARPRO Consulting Team Validation & Qualification Complete guide to IQ, OQ, and PQ in pharmaceutical validation — regulatory basis, documentation requirements, and when each qualification phase applies. IQ, OQ, and PQ are the three qualification phases that demonstrate a system or piece of equipment is installed, operates, and performs as intended. This guide explains what each phase must cover, what documentation is required, and how to structure protocols that satisfy FDA and EU GMP inspectors.

Read the full article →

]]> Thermal Mapping for Pharmaceutical Warehouses and Cold Rooms: A Complete Guide https://www.pharpro.co/insights/thermal-mapping-pharmaceutical-warehouses/ https://www.pharpro.co/insights/thermal-mapping-pharmaceutical-warehouses/ Tue, 26 May 2026 09:00:00 +0300 PHARPRO Consulting Team CQV & Qualification Pharmaceutical temperature mapping guide — when required, how to design a study, sensor placement, excursion handling, and EU GMP Annex 15 requirements. Thermal mapping is mandatory for pharmaceutical storage areas where temperature-sensitive products are held. This guide covers study design, sensor placement rationale, excursion handling, and how to write a mapping report that satisfies EU GMP Annex 15 and WHO GDP expectations.

Read the full article →

]]> Pharmaceutical Validation Software: A Buyer's Guide (2026) https://www.pharpro.co/insights/pharmaceutical-validation-software/ https://www.pharpro.co/insights/pharmaceutical-validation-software/ Tue, 26 May 2026 09:00:00 +0300 PHARPRO Consulting Team Digital Validation Comparing pharmaceutical validation software options in 2026? This guide covers what to look for, how leading platforms differ, and why PHARPRO DVS is built specifically for GxP-regulated teams. Choosing the right pharmaceutical validation software is a significant decision for any GxP-regulated team. This guide compares the main approaches — from generic document management to purpose-built CSV lifecycle platforms — and explains what separates tools that satisfy regulators from those that create more work than they save.

Read the full article →

]]> AI Validation Lifecycle Software for Pharma: PHARPRO DVS Review (2026) https://www.pharpro.co/insights/ai-validation-lifecycle-software-pharma/ https://www.pharpro.co/insights/ai-validation-lifecycle-software-pharma/ Thu, 21 May 2026 09:00:00 +0300 PHARPRO Consulting Team Digital Validation PHARPRO DVS is AI validation lifecycle software for pharmaceutical teams — 30 document builders from URS to VSR, built-in FDA 21 CFR Part 11 and EU GMP Annex 11 compliance, RTM, and same-day deployment. AI-assisted validation software is transforming how pharmaceutical teams produce and manage validation documentation. This article reviews how PHARPRO DVS works, what it covers across the full V-model lifecycle, and how it compares to traditional Word-and-spreadsheet approaches.

Read the full article →

]]> GMP Training Records: What Regulators Expect and How to Stay Audit-Ready https://www.pharpro.co/insights/gmp-training-records-compliance/ https://www.pharpro.co/insights/gmp-training-records-compliance/ Tue, 12 May 2026 09:00:00 +0300 PHARPRO Consulting Team GMP Training GMP training documentation guide — what records regulators require, how to structure your training matrix, and common inspection findings to avoid. GMP training records are among the first documents an inspector requests. Gaps in training matrices, missing effectiveness checks, and inadequate record retention are consistently cited in FDA and EU GMP inspections. This guide explains exactly what records are required and how to structure a training programme that holds up under scrutiny.

Read the full article →

]]> Risk Assessment in CSV: How to Apply GAMP 5 Risk Principles https://www.pharpro.co/insights/risk-assessment-computerised-systems/ https://www.pharpro.co/insights/risk-assessment-computerised-systems/ Tue, 05 May 2026 09:00:00 +0300 PHARPRO Consulting Team CSV & Validation Risk assessment for computerised systems — GAMP 5 categories, risk-based testing, and how to document your risk rationale for regulators under CSV. A risk assessment for computerised systems determines which functions carry GxP impact and how much validation effort each requires. This guide covers the GAMP 5 risk methodology, how to conduct a functional risk assessment, and how to document your rationale in a way regulators find convincing.

Read the full article →

]]> What Is a Validation Master Plan? Requirements and Best Practice https://www.pharpro.co/insights/validation-master-plan-guide/ https://www.pharpro.co/insights/validation-master-plan-guide/ Tue, 28 Apr 2026 09:00:00 +0300 PHARPRO Consulting Team CSV & Validation A practical guide to writing and maintaining a Validation Master Plan (VMP) — what it must contain, who signs it, and how it links to your validation programme. The Validation Master Plan (VMP) is the top-level document that defines the scope, approach, and governance of your validation programme. This guide covers what a VMP must contain, who approves it, and the common gaps regulators find during inspections.

Read the full article →

]]> Pharmaceutical Inspection Readiness: A 7-Step Site Preparation Guide https://www.pharpro.co/insights/pharmaceutical-inspection-readiness/ https://www.pharpro.co/insights/pharmaceutical-inspection-readiness/ Tue, 21 Apr 2026 09:00:00 +0300 PHARPRO Consulting Team QA & Compliance How to prepare your pharmaceutical site for an FDA, EU GMP, or national authority inspection — documentation, staff readiness, and response strategies. Inspection readiness is not a one-time activity — it's an ongoing state. This 7-step guide covers documentation reviews, mock inspections, staff preparation, back-room management, and how to handle inspector requests during the actual inspection.

Read the full article →

]]> Computer System Validation for SaaS and Cloud Applications in Pharma https://www.pharpro.co/insights/csv-saas-cloud-pharma/ https://www.pharpro.co/insights/csv-saas-cloud-pharma/ Tue, 14 Apr 2026 09:00:00 +0300 PHARPRO Consulting Team CSV & Validation How to validate SaaS and cloud systems in pharma GxP — risk approach, vendor qualification, and documentation strategy under GAMP 5 and EU GMP Annex 11. Validating SaaS and cloud-hosted GxP systems requires a different approach than traditional on-premise software. This article explains the GAMP 5 classification for cloud systems, how to qualify vendors, and what documentation a cloud CSV project must produce under EU GMP Annex 11.

Read the full article →

]]> Supplier Qualification in GMP: Vendor Audit Checklist and Process https://www.pharpro.co/insights/supplier-qualification-gmp/ https://www.pharpro.co/insights/supplier-qualification-gmp/ Tue, 07 Apr 2026 09:00:00 +0300 PHARPRO Consulting Team QA & Compliance How to qualify pharmaceutical suppliers under GMP — audit checklist, qualification steps, and ongoing monitoring requirements for contract manufacturers. Supplier qualification is a GMP requirement, not a commercial formality. Regulators expect documented evidence that your suppliers meet defined quality standards. This guide covers the risk-based qualification approach, audit checklist, and quality agreement requirements.

Read the full article →

]]> FDA Warning Letter Response: A Practical Recovery Plan https://www.pharpro.co/insights/fda-warning-letter-response/ https://www.pharpro.co/insights/fda-warning-letter-response/ Wed, 25 Mar 2026 09:00:00 +0300 PHARPRO Consulting Team QA & Compliance Received an FDA Warning Letter? This guide explains how to structure your response, address observations, and restore regulatory standing — step by step. An FDA Warning Letter demands a structured, credible response within 15 business days. This guide explains how to acknowledge observations correctly, present root cause analysis, commit to corrective actions, and restore FDA's confidence in your quality system.

Read the full article →

]]> CAPA Management in Pharmaceutical QA: A Step-by-Step Guide https://www.pharpro.co/insights/capa-management-pharma-guide/ https://www.pharpro.co/insights/capa-management-pharma-guide/ Tue, 10 Mar 2026 09:00:00 +0300 PHARPRO Consulting Team QA & Compliance How to build an effective CAPA system in pharma — from root cause analysis to effectiveness checks. Aligned with FDA 21 CFR Part 11, EU GMP, and ICH Q10. CAPA management is central to every pharmaceutical quality system. Poorly documented CAPAs — with superficial root cause analysis or missing effectiveness checks — are among the most common inspection observations. This step-by-step guide covers how to build a CAPA process that satisfies FDA and EU GMP expectations.

Read the full article →

]]> GAMP 5 Second Edition: Key Changes for Your CSV Programme https://www.pharpro.co/insights/gamp5-second-edition-csv-changes/ https://www.pharpro.co/insights/gamp5-second-edition-csv-changes/ Sat, 15 Mar 2025 09:00:00 +0300 PHARPRO Consulting Team CSV & Validation What ISPE GAMP 5 Second Edition means for your CSV programme — new risk categories, critical thinking principles, and lifecycle documentation changes. ISPE released the second edition of the Good Automated Manufacturing Practice (GAMP 5) guide in 2022. This article breaks down the most significant changes and tells you exactly what to review in your existing programme.

Read the full article →

]]> EU GMP Annex 11: A Practical Compliance Checklist for 2025 https://www.pharpro.co/insights/eu-gmp-annex-11-compliance-checklist/ https://www.pharpro.co/insights/eu-gmp-annex-11-compliance-checklist/ Mon, 10 Feb 2025 09:00:00 +0300 PHARPRO Consulting Team Regulatory Compliance A practical EU GMP Annex 11 compliance checklist for 2025 — covering supplier assessment, validation, data integrity, and audit trail requirements. EU GMP Annex 11 governs computerized systems in pharmaceutical manufacturing. Whether you are preparing for an EMA inspection or reviewing your current compliance state, this checklist covers the areas inspectors assess most closely.

Read the full article →

]]> FDA 21 CFR Part 11: Data Integrity Requirements Explained https://www.pharpro.co/insights/fda-21-cfr-part-11-data-integrity/ https://www.pharpro.co/insights/fda-21-cfr-part-11-data-integrity/ Mon, 20 Jan 2025 09:00:00 +0300 PHARPRO Consulting Team Data Integrity Understand FDA 21 CFR Part 11 data integrity requirements — electronic records, audit trails, electronic signatures, and common compliance gaps to close. 21 CFR Part 11 is the FDA regulation that defines when electronic records and signatures are considered equivalent to paper. Audit trail deficiencies remain among the top five observations in FDA drug inspections.

Read the full article →

]]>